Request Deal Involvement
Vertex Pharmaceuticals to acquire the protease medicines portfolio from Catalyst Biosciences for $60m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Perella Weinberg Partners
legal advisors
Orrick Herrington & Sutcliffe
legal advisors
Potter Anderson & Corroon
or
Principals
vendor
CATALYST BIOSCIENCES
target
CATALYST BIOSCIENCES (PROTEASE MEDICINE PORTFOLIO)
bidder
VERTEX PHARMACEUTICALS INC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite